WASHINGTON, DC – Two Indian Americans, Yale Law School professor Natasha Sarin and surgical oncologist Dr. Vinod Balachandran ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Nurses and APPs provide an essential link between physicians and patients when facilitating and monitoring outcomes with personalized cancer vaccines.

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

A new experimental vaccine could provide fresh hope for women diagnosed with triple-negative breast cancer, a particularly ...

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...